Movatterモバイル変換


[0]ホーム

URL:


Journal Logo

Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.

Export to

Original Articles

In vitrocomparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD)

Sauer, Igor M.*,1,†; Goetz, Max1; Steffen, Ingo1; Walter, Gesa1; Kehr, Daniel C.1; Schwartlander, Ruth1; Hwang, Yoon J.2; Pascher, Andreas1; Gerlach, Joerg C.3; Neuhaus, Peter1

Author Information

1Charité—Campus Virchow General, Visceral and Transplantation Surgery, Universitary Medicine Berlin, a joint institution of the Freie Universität and Humboldt-Universität, Berlin, Germany

2Kyungpook National University Hospital, Department of Surgery, Taegu, Korea

3University of Pittsburgh Medical Center, Department of Surgery, Pittsburgh, Pennsylvania

E-mail:[email protected]

*Address reprint requests to: Charité—Campus Virchow, General, Visceral and Transplantation Surgery, Universitary Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

fax: 49 30 450 559909

Received July 25, 2003; accepted February 02, 2004; previously published online April 26, 2004

Hepatology39(5):p 1408-1414, May 2004. |DOI:10.1002/hep.20195

Abstract

 

The detoxification capacities of single-pass albumin dialysis (SPAD), the molecular adsorbents recirculation system, (MARS) and continuous veno-venous hemodiafiltration (CVVHDF) were comparedin vitro. In each experiment 4,100 mL of toxin-loaded human plasma was processed for 6.5 hours. MARS treatment (n = 6) was undertaken in combination with CVVHDF. For SPAD (n = 6) and CVVHDF (n = 6) a high-flux hollow fiber hemodiafilter (identical to the MARS filter) was used. Levels of ammonia, urea, creatinine, bilirubin, and bile acids were determined. Concentrations before and after application of detoxification procedures were expressed as differences and were compared using the Kruskal-Wallis test.Post hoc comparisons for pairs of groups were adjusted according to Bonferroni-Holm. Time, group, and interaction effects were tested using the nonparametric ANOVA model for repeated measurements. SPAD and CVVHDF induced a significantly greater reduction of ammonia levels than MARS. No significant differences were found among SPAD, MARS, and CVVHDF with respect to other water-soluble substances. SPAD induced a significantly greater reduction in bilirubin levels than MARS. Reductions in bile acid levels were similar for SPAD and MARS. When operating MARS in continuous veno-venous hemodialysis mode, as recommended by the manufacturer, no significant differences in the removal of bilirubin, bile acids, urea, and creatinine were found. However, MARS in continuous veno-venous hemodialysis mode was significantly less efficient in removing ammonia than MARS in CVVHDF mode. In conclusion, the detoxification capacity of SPAD is similar to or even greater than that of MARS. (Hepatology 2004;39:1408-1414.)

Copyright © 2004 American Association for the Study of Liver Diseases.

You can read the full text of this article if you:

Log InAccess through Ovid
Email to Colleague

Colleague's E-mail is Invalid

Your Name:
Colleague's Email:
Separate multiple e-mails with a (;).
Message:

Your message has been successfully sent to your colleague.



Some error has occurred while processing your request. Please try after some time.


[8]ページ先頭

©2009-2025 Movatter.jp